109 related articles for article (PubMed ID: 16713069)
1. Interview with Jack Schalken. PCA3 and its use as a diagnostic test in prostate cancer. Interview by Christine McKillop.
Schalken J
Eur Urol; 2006 Jul; 50(1):153-4. PubMed ID: 16713069
[No Abstract] [Full Text] [Related]
2. Re: Christine McKillop. Interview with Jack Schalken: PCA3 and its use as a diagnostic test in prostate cancer. Eur Urol 2006;50:153-154.
Shaw G; Purkiss T; Oliver RT; Prowse DM
Eur Urol; 2007 Mar; 51(3):860-2. PubMed ID: 17049717
[No Abstract] [Full Text] [Related]
3. Molecular PCA3 diagnostics on prostatic fluid.
van Gils MP; Cornel EB; Hessels D; Peelen WP; Witjes JA; Mulders PF; Rittenhouse HG; Schalken JA
Prostate; 2007 Jun; 67(8):881-7. PubMed ID: 17440939
[TBL] [Abstract][Full Text] [Related]
4. The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.
van Gils MP; Hessels D; van Hooij O; Jannink SA; Peelen WP; Hanssen SL; Witjes JA; Cornel EB; Karthaus HF; Smits GA; Dijkman GA; Mulders PF; Schalken JA
Clin Cancer Res; 2007 Feb; 13(3):939-43. PubMed ID: 17289888
[TBL] [Abstract][Full Text] [Related]
5. [Value of urinary PCA3 test for prostate cancer diagnosis].
Vlaeminck-Guillem V; Ruffion A; Andre J
Prog Urol; 2008 May; 18(5):259-65. PubMed ID: 18538269
[TBL] [Abstract][Full Text] [Related]
6. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
Marks LS; Fradet Y; Deras IL; Blase A; Mathis J; Aubin SM; Cancio AT; Desaulniers M; Ellis WJ; Rittenhouse H; Groskopf J
Urology; 2007 Mar; 69(3):532-5. PubMed ID: 17382159
[TBL] [Abstract][Full Text] [Related]
7. A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy.
Sokoll LJ; Ellis W; Lange P; Noteboom J; Elliott DJ; Deras IL; Blase A; Koo S; Sarno M; Rittenhouse H; Groskopf J; Vessella RL
Clin Chim Acta; 2008 Mar; 389(1-2):1-6. PubMed ID: 18061575
[TBL] [Abstract][Full Text] [Related]
8. PCA3 improves diagnosis of prostate cancer.
Kirby R
Practitioner; 2007 Jan; 251(1690):18, 21, 23. PubMed ID: 17290852
[No Abstract] [Full Text] [Related]
9. Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8-16.
Jung M; Xu C; Spethmann J; Johannsen M; Deger S; Stephan C; Loening SA; Jung K
Eur Urol; 2004 Aug; 46(2):271-2. PubMed ID: 15245824
[No Abstract] [Full Text] [Related]
10. PCA3: a molecular urine assay for predicting prostate biopsy outcome.
Deras IL; Aubin SM; Blase A; Day JR; Koo S; Partin AW; Ellis WJ; Marks LS; Fradet Y; Rittenhouse H; Groskopf J
J Urol; 2008 Apr; 179(4):1587-92. PubMed ID: 18295257
[TBL] [Abstract][Full Text] [Related]
11. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.
Nakanishi H; Groskopf J; Fritsche HA; Bhadkamkar V; Blase A; Kumar SV; Davis JW; Troncoso P; Rittenhouse H; Babaian RJ
J Urol; 2008 May; 179(5):1804-9; discussion 1809-10. PubMed ID: 18353398
[TBL] [Abstract][Full Text] [Related]
12. PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting.
Shappell SB; Fulmer J; Arguello D; Wright BS; Oppenheimer JR; Putzi MJ
Urology; 2009 Feb; 73(2):363-8. PubMed ID: 18995890
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer chemotherapy. Interview by Christine McKillop.
Sternberg CN
Eur Urol; 2007 Apr; 51(4):1136-8. PubMed ID: 17250951
[No Abstract] [Full Text] [Related]
14. Quantitative real-time RT-PCR assay for PCA3.
Väänänen RM; Rissanen M; Kauko O; Junnila S; Väisänen V; Nurmi J; Alanen K; Nurmi M; Pettersson K
Clin Biochem; 2008 Jan; 41(1-2):103-8. PubMed ID: 17996198
[TBL] [Abstract][Full Text] [Related]
15. Progensa PCA3 test for prostate cancer detection.
de la Taille A
Expert Rev Mol Diagn; 2007 Sep; 7(5):491-7. PubMed ID: 17892357
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).
Kirby RS; Fitzpatrick JM; Irani J
BJU Int; 2009 Feb; 103(4):441-5. PubMed ID: 19154510
[TBL] [Abstract][Full Text] [Related]
17. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer.
Hessels D; Smit FP; Verhaegh GW; Witjes JA; Cornel EB; Schalken JA
Clin Cancer Res; 2007 Sep; 13(17):5103-8. PubMed ID: 17785564
[TBL] [Abstract][Full Text] [Related]
18. [The search for better markers for prostate cancer than prostate-specific antigen].
Schenk-Braat EA; Bangma CH
Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1286-90. PubMed ID: 16821452
[TBL] [Abstract][Full Text] [Related]
19. Does PCA3 help identify clinically significant prostate cancer?
Loeb S
Eur Urol; 2008 Nov; 54(5):980-1. PubMed ID: 18684556
[No Abstract] [Full Text] [Related]
20. Immunological prostate cancer test developed.
J Med Assoc State Ala; 1973 Oct; 43(4):278. PubMed ID: 4583455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
